Arbutus Biopharma Corp APIC, Share-based Payment Arrangement, Recognition and Exercise
Arbutus Biopharma Corp (ABUS) reported APIC, Share-based Payment Arrangement, Recognition and Exercise of $2.71 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions · last filed 2014-11-07
CAD
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 12 month |
|---|---|
| 2012-12-31 | 981.66K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 626.12K CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 650.62K CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | 265.69K CAD 20-F · filed 2012-03-27 |
USD
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 3 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 6 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 9 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 12 month |
|---|---|---|---|---|
| 2014-09-30 | $445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.53M derived: sum of 2 quarters · filed 2014-11-07 | $2.71M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $2.27M 10-Q · filed 2014-08-14 | ||
| 2014-03-31 | $1.19M 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | $903.00K 10-K · filed 2014-03-28 | |||
| 2012-12-31 | $982.29K 10-K · filed 2014-03-28 | |||
| 2011-12-31 | $633.45K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |